BHC
Price
$6.78
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
3.86B
3 days until earnings call
TEVA
Price
$16.54
Change
+$0.21 (+1.29%)
Updated
Jul 25 closing price
Capitalization
15.06B
3 days until earnings call
Interact to see
Advertisement

BHC vs TEVA

Header iconBHC vs TEVA Comparison
Open Charts BHC vs TEVABanner chart's image
Bausch Health Companies
Price$6.78
Change-$0.00 (-0.00%)
Volume$673
Capitalization3.86B
Teva Pharmaceutical Industries
Price$16.54
Change+$0.21 (+1.29%)
Volume$9.21M
Capitalization15.06B
BHC vs TEVA Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. TEVA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and TEVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BHC: $6.78 vs. TEVA: $16.54)
Brand notoriety: BHC and TEVA are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 0% vs. TEVA: 87%
Market capitalization -- BHC: $3.86B vs. TEVA: $15.06B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whileTEVA’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • TEVA’s FA Score: 1 green, 4 red.
According to our system of comparison, BHC is a better buy in the long-term than TEVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 3 TA indicator(s) are bullish while TEVA’s TA Score has 3 bullish TA indicator(s).

  • BHC’s TA Score: 3 bullish, 5 bearish.
  • TEVA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BHC and TEVA are a bad buy in the short-term.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а +7.45% price change this week, while TEVA (@Pharmaceuticals: Other) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

BHC is expected to report earnings on Jul 30, 2025.

TEVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than BHC($3.86B). TEVA has higher P/E ratio than BHC: TEVA (22.62) vs BHC (13.39). BHC YTD gains are higher at: -15.881 vs. TEVA (-24.955). BHC has higher annual earnings (EBITDA): 2.2B vs. TEVA (1.56B). TEVA has more cash in the bank: 3.23B vs. BHC (947M). TEVA has less debt than BHC: TEVA (20.2B) vs BHC (22.4B). TEVA has higher revenues than BHC: TEVA (15.8B) vs BHC (8.76B).
BHCTEVABHC / TEVA
Capitalization3.86B15.1B26%
EBITDA2.2B1.56B141%
Gain YTD-15.881-24.95564%
P/E Ratio13.3922.6259%
Revenue8.76B15.8B55%
Total Cash947M3.23B29%
Total Debt22.4B20.2B111%
FUNDAMENTALS RATINGS
BHC vs TEVA: Fundamental Ratings
BHC
TEVA
OUTLOOK RATING
1..100
2956
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
4861
P/E GROWTH RATING
1..100
9713
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for TEVA (69) in the Pharmaceuticals Generic industry. This means that BHC’s stock grew somewhat faster than TEVA’s over the last 12 months.

TEVA's Profit vs Risk Rating (67) in the Pharmaceuticals Generic industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that TEVA’s stock grew somewhat faster than BHC’s over the last 12 months.

TEVA's SMR Rating (94) in the Pharmaceuticals Generic industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TEVA’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as TEVA (61) in the Pharmaceuticals Generic industry. This means that BHC’s stock grew similarly to TEVA’s over the last 12 months.

TEVA's P/E Growth Rating (13) in the Pharmaceuticals Generic industry is significantly better than the same rating for BHC (97) in the Pharmaceuticals Other industry. This means that TEVA’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCTEVA
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
78%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWFG52.870.26
+0.50%
NYLI Winslow Focused Large Cap Gr ETF
SOR43.830.07
+0.15%
Source Capital
PSQO20.580.01
+0.05%
Palmer Square Credit Opportunities ETF
GGT4.27-0.01
-0.23%
THE Gabelli Multimedia Trust
SIL50.05-0.39
-0.77%
Global X Silver Miners ETF

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and PAHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and PAHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
N/A
PAHC - BHC
26%
Poorly correlated
-0.88%
ELAN - BHC
26%
Poorly correlated
+1.57%
TEVA - BHC
26%
Poorly correlated
+1.29%
SWDCF - BHC
25%
Poorly correlated
N/A
TLRY - BHC
25%
Poorly correlated
-2.03%
More

TEVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+1.29%
AMRX - TEVA
38%
Loosely correlated
+0.75%
ELAN - TEVA
31%
Poorly correlated
+1.57%
VTRS - TEVA
30%
Poorly correlated
+0.64%
CGC - TEVA
26%
Poorly correlated
+2.70%
BHC - TEVA
26%
Poorly correlated
N/A
More